| Pharmaceutical Information |
| Drug Name |
Nisoldipine |
| Drug ID |
BADD_D01570 |
| Description |
Nisoldipine is a 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nisoldipine prevents calcium-dependent smooth muscle contraction and subsequent vasoconstriction. Nisoldipine may be used in alone or in combination with other agents in the management of hypertension. |
| Indications and Usage |
For the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents. |
| Marketing Status |
approved |
| ATC Code |
C08CA07 |
| DrugBank ID |
DB00401
|
| KEGG ID |
D00618
|
| MeSH ID |
D015737
|
| PubChem ID |
4499
|
| TTD Drug ID |
D0S5CU
|
| NDC Product Code |
0378-2097; 66993-473; 13672-042; 0378-2222; 0378-2099; 70515-503; 49706-1607; 13672-041; 13672-043; 0378-2223; 66993-472; 0378-2096; 0378-2098; 70515-501; 0378-2224; 66993-475; 70515-500 |
| UNII |
4I8HAB65SZ
|
| Synonyms |
Nisoldipine | Bay K 5552 |
|
| Chemical Information |
| Molecular Formula |
C20H24N2O6 |
| CAS Registry Number |
63675-72-9 |
| SMILES |
CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
